Intercept Pharmaceuticals
About Intercept PharmaceuticalsIntercept Pharmaceuticals Inc. is an American biopharmaceutical company incorporated in 2002 focusing on the development of novel synthetic bile acid analogs to treat chronic liver diseases such as primary biliary cirrhosis (PBC) now called primary bilia
About Intercept PharmaceuticalsIntercept Pharmaceuticals Inc. is an American biopharmaceutical company incorporated in 2002 focusing on the development of novel synthetic bile acid analogs to treat chronic liver diseases such as primary biliary cirrhosis (PBC) now called primary bilia